Zicheng Liu

Title: Zicheng Liu: Innovator in Liraglutide Synthesis

Introduction

Zicheng Liu is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of pharmaceutical synthesis, particularly in the development of liraglutide, a medication used for the treatment of type 2 diabetes. His innovative approach has led to advancements in the synthesis methods that enhance the efficiency and cost-effectiveness of liraglutide production.

Latest Patents

Zicheng Liu holds a patent for a synthesis method for liraglutide with low racemate impurity. This method involves several steps, including the synthesis of a propeptide and the coupling of multiple peptides using a solid-phase synthesis technique. The process results in a liraglutide resin that can be cracked, purified, and freeze-dried to yield the final product. This innovative synthesis method effectively reduces the generation of racemization impurities, ensuring a high yield of liraglutide while significantly lowering production costs.

Career Highlights

Zicheng Liu is currently associated with Shenzhen Jymed Technology Co., Ltd., where he continues to work on innovative solutions in pharmaceutical synthesis. His expertise in peptide synthesis and purification has positioned him as a key player in the industry. Liu's work not only contributes to the scientific community but also has practical implications for the production of essential medications.

Collaborations

Zicheng Liu collaborates with talented professionals in his field, including Xinyu Li and Qin Zhi. These collaborations enhance the research and development efforts at Shenzhen Jymed Technology Co., Ltd., fostering an environment of innovation and progress.

Conclusion

Zicheng Liu's contributions to the synthesis of liraglutide exemplify the impact of innovative thinking in the pharmaceutical industry. His work not only advances scientific knowledge but also improves the accessibility and affordability of vital medications.